MTVA
MTVA
NASDAQ · Biotechnology

Metavia Inc

$1.82
+0.09 (+5.20%)
As of Feb 8, 2:31 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 913.8K 821.5K 988.8K
Net Income -134,164 -149,522 -162,197
EPS
Profit Margin -14.7% -18.2% -16.4%
Rev Growth +16.4% +11.0% +21.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.84M 2.52M 2.63M
Total Equity 2.63M 2.94M 3.09M
D/E Ratio 1.08 0.86 0.85
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -201,888 -178,889 -216,043
Free Cash Flow -124,461 -98,758 -111,181